Studying a therapy target for nerve pain after chemotherapy
Part of Brain & nervous system clinical trials.
This study looks at “TRP channels,” which are part of how nerves sense pain and temperature, to understand nerve pain (neuropathy) after chemotherapy. It may help improve how future treatments prevent or reduce nerve pain in people who have had certain chemotherapy drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re a non-smoker for at least the last 6 months (smoking includes vaping).
- Your body weight (BMI) falls within the study’s range (healthy volunteers or specific patient groups).
- You must be able to understand study steps and sign written consent.
- You must match the study’s allowed age range for the correct group (healthy: 18–45; some patients: up to 75).
- For patient groups: you had paclitaxel or oxaliplatin chemotherapy and may have nerve pain symptoms in the hands.
- For patient groups: your timing and neuropathy severity must fit their scoring system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This Phase 3 trial tests whether a capsaicin patch works better than duloxetine tablets to reduce painful nerve pain after chemotherapy. It aims to help people whose “gloves and socks” nerve pain has lasted after chemo.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
This study tests whether a gentle, non-invasive brain stimulation (over the motor cortex) can help relieve pain caused by nerve damage from chemotherapy. It is for people who have completed cancer treatment at least 3 months ago and have ongoing painful neuropathy.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.